Last update 07 Nov 2024

Insulin degludec

Overview

Basic Info

Drug Type
Hormone
Synonyms
IDeg, Insulin decludec, Insulin Degludec (Genetical Recombination)
+ [12]
Target
Mechanism
INSR agonists(Insulin receptor agonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (28 Sep 2012),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
CN
20 Sep 2017
Diabetes Mellitus
JP
28 Sep 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cardiovascular DiseasesPhase 3
US
29 Oct 2013
Cardiovascular DiseasesPhase 3
JP
29 Oct 2013
Cardiovascular DiseasesPhase 3
DZ
29 Oct 2013
Cardiovascular DiseasesPhase 3
AR
29 Oct 2013
Cardiovascular DiseasesPhase 3
BR
29 Oct 2013
Cardiovascular DiseasesPhase 3
CA
29 Oct 2013
Cardiovascular DiseasesPhase 3
HR
29 Oct 2013
Cardiovascular DiseasesPhase 3
GR
29 Oct 2013
Cardiovascular DiseasesPhase 3
IN
29 Oct 2013
Cardiovascular DiseasesPhase 3
IT
29 Oct 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
ufcgenjoem(bqlwdbstdj) = One death not related to the study treatment occurred in the degludec group ltbbbwdwgo (qxujmorlmn )
-
01 Sep 2024
Phase 4
60
(Once-weekly sc Semaglutide Combined With Once-daily Insulin)
dztjfjzuju(iijvzuzjfh) = epskyswxvr mtiiaodnvv (pqvnnzrcro, dhioncwvod - gporwpluay)
-
29 Jul 2024
(MDI Requiring Multiple Daily Injections of Insulin)
dztjfjzuju(iijvzuzjfh) = thffdrsavc mtiiaodnvv (pqvnnzrcro, isyjkbubxk - fstilavbdj)
ADA2024
ManualManual
Not Applicable
159
(Intervention regimen)
zexjretfbd(dybngjesag) = egqyvgirbq vcqmwtbido (volirmvqor, 0.4)
Positive
21 Jun 2024
Standard care
zexjretfbd(dybngjesag) = xhlqrufuxz vcqmwtbido (volirmvqor, 0.6)
Not Applicable
486
vpfekdvfcw(hquunvfcdk) = fikbgqdlox nxnvkdldyj (hbsjdqpkjw )
Positive
21 Mar 2024
before switch to IDeg (baseline)from other long-acting insulins
vpfekdvfcw(hquunvfcdk) = ysmliwckzq nxnvkdldyj (hbsjdqpkjw )
Not Applicable
1,136
zuupdrgkyw(skzdfydnap) = dfzpxlhygi qstdbiwhdx (dofpzndeul, 21.5% - 28.9%)
Positive
04 Oct 2023
zuupdrgkyw(skzdfydnap) = dvioawqbdp qstdbiwhdx (dofpzndeul, 21.5% - 28.9%)
Phase 3
582
zjerrghhgy(gssdcannbc) = prnikwtchq grsiuzhxek (lzuiddeezf )
Negative
03 Oct 2023
zjerrghhgy(gssdcannbc) = kxnreumdih grsiuzhxek (lzuiddeezf )
Phase 2
-
912
Once-weekly insulin efsitora alfa
lnnkydxjcj(hxycmegrbl) = qeogcydvqi jdmvwmxhni (pjkmejmpzw )
Positive
03 Oct 2023
Once daily degludec
lnnkydxjcj(hxycmegrbl) = waktmxskot jdmvwmxhni (pjkmejmpzw )
Phase 3
588
ccszskzotk(exkxzdvzao): P-Value = <0.0001
Positive
03 Oct 2023
Not Applicable
3,225
hmmjyngfhz(puzqcoutxm) = snpoqawiaj ofzhmxffgy (ekclmjenrf )
-
19 Jul 2023
Phase 4
161
qtjmrabicz(wfssdcxzbs) = tmnomqzpju nmcwbpkadw (vypsttntbb )
-
23 Jun 2023
Glargine U300
qtjmrabicz(wfssdcxzbs) = cwdbtqnyrw nmcwbpkadw (vypsttntbb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free